培地の世界市場2020–2027:培地種類別(脱水培地、調製培地、発色培地)、用途別(癌研究、生物薬剤学研究、再生医療、幹細胞技術、創薬、その他)、エンドユーザー別(バイオテクノロジー・製薬産業、学術研究所・研究センター、病院・診断センター、その他)、地域別

【英語タイトル】Culture Media Market, by Media type (Dehydrated Culture Media, Prepared Culture Media, Chromogenic Culture Media), Application (Cancer Research, Biopharmaceutical Research, Regenerative Medicine, Stem Cell Technologies, Drug Discovery, Others), End-user (Biotech & Pharmaceutical Industry, Academic Institute & Research Centers, Hospital & Diagnostic Centers, Others), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2020–2027

Research Diveが出版した調査資料(RDV20NB121)・商品コード:RDV20NB121
・発行会社(調査会社):Research Dive
・発行日:2020年10月
・ページ数:230
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:生命科学
◆販売価格オプション(消費税別)
Individual UserUSD5,700 ⇒換算¥592,800見積依頼/購入/質問フォーム
Business UserUSD10,700 ⇒換算¥1,112,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本市場調査レポートでは、培地の世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症の影響、培地種類別(脱水培地、調製培地、発色培地)分析、用途別(癌研究、生物薬剤学研究、再生医療、幹細胞技術、創薬、その他)分析、エンドユーザー別(バイオテクノロジー・製薬産業、学術研究所・研究センター、病院・診断センター、その他)分析、地域別分析、企業情報などの項目を掲載しています。
・調査手法
・エグゼクティブサマリー
・市場概要
・新型コロナウイルス感染症の影響
・培地の世界市場規模:培地種類別(脱水培地、調製培地、発色培地)
・培地の世界市場規模:用途別(癌研究、生物薬剤学研究、再生医療、幹細胞技術、創薬、その他)
・培地の世界市場規模:エンドユーザー別(バイオテクノロジー・製薬産業、学術研究所・研究センター、病院・診断センター、その他)
・培地の世界市場規模:地域別
・企業情報
【レポートの概要】

The global culture media market was estimated to be $2,975.6 million in 2019, growing at a CAGR of 7.7% from 2020 to 2027 to reach $ 5,398.6 million by 2027, according to Research Dive.
COVID-19 impact on Global Culture Media Market:
Before COVID 19 pandemic the global culture media market was expected to witness significant growth to reach $ 5,398.6 million by 2027. The novel coronavirus pandemic has a significant impact on the growth of the culture media market. The pandemic has affected the global supply chain owing to which the price of raw material has significantly increased. Furthermore, due to the stringent government regulation and COVID guidelines, companies have faced the problem with logistic and workforce management. Furthermore, owing to the disruption is supply chain and logistic, price of finish goods have skyrocketed, thereby putting the financial burden on the buyer.
Market Dynamics:
The global market is driven by growing R&D investment for development of novel therapeutics to treat life threatening diseases. The growing prevalence of chronic and incurable diseases such as cancer, cardiovascular ailment, Parkinson’s diseases, diabetes, and Alzheimer disease has fostered need for advance and innovative medicine, owing to which companies are investing in development of advanced and innovative such cell and gene therapies.
The pharmaceutical and biopharmaceutical companies operating in the biologics market are investing in R&D activities to develop next-generation biologics such as antibody-drug conjugates, fusion proteins, biospecific, cell and gene therapy that will be more effective compare to existing biologics. These next-generation molecules are projected to have better efficacy against the target disease as well as have the ability to treat more than one aspect of the disease. Such factors are expected to fuel demand for the culture media in foreseeable future
The global culture media market is categorized into media type, application, end-user, and region.
Culture Media Market, Based on Media Type:
Based on media type, the global market has been segmented into dehydrated culture media, prepared culture media, and chromogenic culture media. The dehydrated media held major market share of 46.9% in 2019. Dehydrated culture media is cost-effective and easy to prepare owing to which it is widely used in most clinical and laboratory settings. The prepared culture media is expected to witness fastest growth over the forecast period. The growing demand for high-quality, as well as the volume and range of media required, led to the development of the ready-to-use prepared culture media.
Culture Media Market, Based on Application:
Based on application, the market is classified into cancer research, biopharmaceutical research, regenerative medicines, stem cell technologies, drug discovery, and others. Cancer research market was valued at $821.7 million in 2019, and is projected to reach $1,493.9 million by 2027, growing at a CAGR of 7.8% from 2020 to 2027. However, stem cell technologies segment is expected to grow at highest CAGR of 8.9% from 2020 to 2027 owing to the growing awareness related to the preservation of embryo cell.
Culture Media Market, Based on End User:
Based on end user, the market is segmented into biotech & pharmaceutical industry, academic institutes & research lab, hospitals & diagnostic centers, and others. The biotech and pharmaceutical segment was the highest contributor to the market, with $1,505.9 million in 2019, and is estimated to reach $2,752.3 million by 2027, at a CAGR of 7.8% during the forecast period. The biotech & pharmaceutical and academic & research lab media segments collectively accounted for around 85.0% market share in 2019, with the former constituting around 50.6% share.
Culture Media Market, Regional Insights:
Geographically, the global culture media market was investigated across regions such as North America, Europe, Asia-Pacific and LAMEA. North America was the highest revenue contributor, accounting for $1,136.7 million in 2019, and is estimated to reach $470.39136 million by 2027, with a CAGR of 26.4%. North America is estimated to reach $1,927.3 million by 2027, at a significant CAGR of 6.8%. North America and Asia-Pacific collectively accounted for around 62.0% share in 2019, with the former constituting around 38.2% share.
Key Participants in the Global Culture Media Market:
The Key players operating in the global culture media market include BioMÉerieux SA, BD, Thermo Fisher Scientific Inc., HiMedia Laboratories Private Limited, Fujifilm Holdings Corporation, Merck & Co., Corning Incorporated, Lonza, CellGenix GmbH, and Sartorius AG. The players operating the market are focusing on partnership and acquisition to gain market share.

【レポートの目次】

CHAPTER 1: INTRODUCTION

1.1. Research methodology

1.1.1. Desk research
1.1.2. Real-time insights and validation
1.1.3. Forecast model
1.1.4. Assumptions & forecast parameters

1.1.4.1. Assumptions
1.1.4.2. Forecast parameters

CHAPTER 2: EXECUTIVE SUMMARY

2.1. 360° summary
2.2. Media type trends
2.3. Application trends
2.4. End user trends

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key takeaways

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Top winning strategies, by year
3.2.2.2. Top winning strategies, by development
3.2.2.3. Top winning strategies, by company
3.2.3. Top player positioning

3.3. Porter’s five forces analysis
3.4. Market dynamics

3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities

3.5. Technology landscape
3.6. Market value chain analysis
3.7. Strategic overview

CHAPTER 4: IMPACT OF COVID19 ON GLOBAL CULTURE MEDIA MARKET

4.1. Introduction
4.2. COVID-19 health assessment
4.3. Impact of COVID-19 on the global economy
4.4. Impact of COVID-19 on global culture media market

4.4.1. Social impact
4.4.2. Technological impact
4.4.3. Investment scenario
4.5. Culture media market size and forecast, by region, 2019-2021

CHAPTER 5: GLOBAL CULTURE MEDIA MARKET, BY MEDIA TYPE

5.1. Overview

5.1.1. Market size and forecast, by media type

5.2. Dehydrated culture media

5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis, by country

5.3. Prepared culture media

5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis, by country

5.4. Chromogenic culture media

5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis, by country

CHAPTER 6: GLOBAL CULTURE MEDIA MARKET, BY APPLICATION

6.1. Overview

6.1.1. Market size and forecast, by application

6.2. Cancer research

6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis, by country

6.3. Biopharmaceutical research

6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis, by country

6.4. Regenerative medicine

6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis, by country

6.5. Stem cell technologies

6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis, by country

6.6. Drug discovery

6.6.1. Key market trends, growth factors and opportunities
6.6.2. Market size and forecast, by region
6.6.3. Market share analysis, by country

6.7. Others

6.7.1. Key market trends, growth factors and opportunities
6.7.2. Market size and forecast, by region
6.7.3. Market share analysis, by country

CHAPTER 7: GLOBAL CULTURE MEDIA MARKET, BY END USER

7.1. Overview

7.1.1. Market size and forecast, by end user

7.2. Biotech & Pharmaceutical Industry

7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis, by country

7.3. Academic & Research lab

7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis, by country

7.4. Hospital & Diagnostic centers

7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis, by country

7.5. Others

7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by region
7.5.3. Market share analysis, by country

CHAPTER 8: GLOBAL CULTURE MEDIA MARKET, BY REGION

8.1. Overview

8.1.1. Market size and forecast, by region

8.2. North America

8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by media type
8.2.3. Market size and forecast, by application
8.2.4. Market size and forecast, by end user
8.2.5. Market size and forecast, by country
8.2.6. U.S.

8.2.6.1. Market size and forecast, by media type

8.2.7. Market size and forecast, by application
8.2.8. Market size and forecast, by end user
8.2.9. Canada

8.2.9.1. Market size and forecast, by media type

8.2.10. Market size and forecast, by application

8.2.11. Market size and forecast, by end user

8.2.12. Mexico

8.2.12.1. Market size and forecast, by media type
8.2.13. Market size and forecast, by application
8.2.14. Market size and forecast, by end user

8.3. Europe

8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by media type
8.3.3. Market size and forecast, by application
8.3.4. Market size and forecast, by end-user
8.3.5. Market size and forecast, by country
8.3.6. Germany

8.3.6.1. Market size and forecast, by media type
8.3.6.2. Market size and forecast, by application
8.3.6.3. Market size and forecast, by end-user

8.3.7. France

8.3.7.1. Market size and forecast, by media type
8.3.7.2. Market size and forecast, by application
8.3.7.3. Market size and forecast, by end-user

8.3.8. UK

8.3.8.2. Market size and forecast, by application
8.3.8.3. Market size and forecast, by end-user

8.3.9. Italy

8.3.9.1. Market size and forecast, by media type
8.3.9.2. Market size and forecast, by application
8.3.9.3. Market size and forecast, by end-user

8.3.10. Spain

8.3.10.1. Market size and forecast, by media type
8.3.10.2. Market size and forecast, by application
8.3.10.3. Market size and forecast, by end-user

8.3.11. Rest of Europe

8.3.11.1. Market size and forecast, by media type
8.3.11.2. Market size and forecast, by application
8.3.11.3. Market size and forecast, by end-user

8.4. Asia-Pacific

8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by media type

8.4.2.1. Market size and forecast, by application
8.4.2.2. Market size and forecast, by end-user

8.4.3. Market size and forecast, by country
8.4.4. Japan

8.4.4.1. Market size and forecast, by media type
8.4.4.2. Market size and forecast, by application
8.4.4.3. Market size and forecast, by end-user

8.4.5. China

8.4.5.1. Market size and forecast, by media type
8.4.5.2. Market size and forecast, by application
8.4.5.3. Market size and forecast, by end-user

8.4.6. Australia

8.4.6.1. Market size and forecast, by media type
8.4.6.2. Market size and forecast, by application
8.4.6.3. Market size and forecast, by end-user

8.4.7. India

8.4.7.1. Market size and forecast, by media type
8.4.7.2. Market size and forecast, by application
8.4.7.3. Market size and forecast, by end-user

8.4.8. South Korea

8.4.8.1. Market size and forecast, by media type
8.4.8.2. Market size and forecast, by application
8.4.8.3. Market size and forecast, by end-user

8.4.9. Rest of Asia-Pacific

8.4.9.1. Market size and forecast, by media type
8.4.9.2. Market size and forecast, by application
8.4.9.3. Market size and forecast, by end-user

8.5. LAMEA

8.5.1. Key market trends, growth factors, and opportunities

8.5.1.1. Market size and forecast, by media type
8.5.1.2. Market size and forecast, by application
8.5.1.3. Market size and forecast, by end-user

8.5.2. Market size and forecast, by country
8.5.3. Latin America

8.5.3.1. Market size and forecast, by media type
8.5.3.2. Market size and forecast, by application
8.5.3.3. Market size and forecast, by end-user

8.5.4. Middle East

8.5.4.1. Market size and forecast, by media type
8.5.4.2. Market size and forecast, by application
8.5.4.3. Market size and forecast, by end-user

8.5.5. Africa

8.5.5.1. Market size and forecast, by media type
8.5.5.2. Market size and forecast, by application
8.5.5.3. Market size and forecast, by end-user

CHAPTER 9: COMPANY PROFILES

9.1. BioMérieux SA

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments

9.2. BD

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product portfolio
9.2.5. Business performance

9.3. THERMO FISHER SCIENTIFIC INC.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Product portfolio
9.3.5. Business performance
9.3.6. Key strategic moves and developments

9.4. HIMEDIA LABORATORIES

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product portfolio
9.4.5. Key strategic moves and developments

9.5. CELLGENIX

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product portfolio

9.6. LONZA

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments

9.7. CORNING INCORPORATED

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product portfolio
9.7.5. Business performance

9.8. FUJIFILM HOLDINGS CORPORATION

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Product portfolio
9.8.5. Business performance
9.8.6. Key strategic moves and developments

9.9. MERCK & Co.

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product portfolio
9.9.5. Business performance
9.9.6. Key strategic moves and developments

9.10. SARTORIUS AG

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments



★調査レポート[培地の世界市場2020–2027:培地種類別(脱水培地、調製培地、発色培地)、用途別(癌研究、生物薬剤学研究、再生医療、幹細胞技術、創薬、その他)、エンドユーザー別(バイオテクノロジー・製薬産業、学術研究所・研究センター、病院・診断センター、その他)、地域別] (コード:RDV20NB121)販売に関する免責事項を必ずご確認ください。
★調査レポート[培地の世界市場2020–2027:培地種類別(脱水培地、調製培地、発色培地)、用途別(癌研究、生物薬剤学研究、再生医療、幹細胞技術、創薬、その他)、エンドユーザー別(バイオテクノロジー・製薬産業、学術研究所・研究センター、病院・診断センター、その他)、地域別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆